Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Innovate Biopharmaceuticals Announces Promising Results of Larazotide in NASH Study
Innovate Biopharmaceuticals Announces Promising Results of Larazotide in NASH Study
Innovate Biopharmaceuticals Announces Promising Results of Larazotide in NASH Study
Submitted by
admin
on October 29, 2018 - 9:57am
Source:
CP Wire
News Tags:
Innovate Biopharmaceuticals
larazotide acetate
NASH
celiac disease
Headline:
Innovate Biopharmaceuticals Announces Promising Results of Larazotide in NASH Study
snippet:
Larazotide is a tight junction regulator
The drug is also in Ph III trials for celiac disease
The FDA awarded fast track status to Larazotide for celiac
If approved, Larazotide would be the first drug approved for celiac
Do Not Allow Advertisers to Use My Personal information
